| Product name | CAS | Purity |
| Imatinib mesylate | 220127-57-1 | 99% |
| Imatinib | 152459-95-5 | 99% |
| 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride | 106261-49-8 | 99% |
| N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine | 152460-09-8 | 99% |
| N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine | 152460-10-1 | 99% |
| | 184475-35-2 | 99% |
| Lapatinib | 231277-92-2 | 99% |
| 3,4-Dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate | 179688-53-0 | 99% |
| 4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ol | 184475-71-6 | 99% |
| 7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one | 199327-61-2 | 99% |
| Erlotinib hydrochloride | 183319-69-9 | 99% |
| Erlotinib | 183321-74-6 | 99% |
| 6,7-Bis-(2-methoxyethoxy)-4(3H)-quinazolinone | 179688-29-0 | 99% |
| 4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline | 183322-18-1 | 99% |
| Sunitinib Malate | 341031-54-7 | 99% |
| Sunitinib | 557795-19-4 | 99% |
| 5-Fluoro-2-oxindole | 56341-41-4 | 99% |
| 5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid | 253870-02-9 | 99% |
| Ethyl 2,4-dimethyl-1H-pyrrole-3-carboxylate | 2199-51-1 | 99% |
| Diethyl 2,4-dimethylpyrrole-3,5-dicarboxylate | 2436-79-5 | 99% |
| 4-(Ethoxycarbonyl)-3,5-dimethyl-1H-pyrrole-2-carboxylic acid | 5442-91-1 | 99% |
| Ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate | 2199-59-9 | 99% |
| N-(2-(Diethylamino)ethyl)-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide | 356068-86-5 | 99% |
| 5-((Z)-(5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid | 356068-93-4 | 99% |
| 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline | 641571-11-1 | 99% |
| Dasatinib | 302962-49-8 | 99% |
| Dasatinib monohydrate | 863127-77-9 | 99% |
| 2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide | 302964-24-5 | 99% |
| N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine | 231278-20-9 | 99% |
| Nilotinib | 641571-10-0 | 99% |
| 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid | 641569-94-0 | 99% |
| 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline | 641571-11-1 | 99% |
| Nilotinib hcl monohydrate | 923288-90-8 | 99% |
| Lapatinib ditosylate | 388082-78-8 | 99% |
| 3-Chloro-4-(3-fluorobenzyloxy)nitrobenzene | 443882-99-3 | 99% |
| 3-Chloro-4-(3-fluorobenzyloxy)aniline | 202197-26-0 | 99% |
| Nilotinib | 641571-10-0 | 99% |
| 5-[4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl]-2-furaldehyde | 231278-84-5 | 99% |
| 2-Formylfuran-5-boronic acid | 27329-70-0 | 99% |
| 2-Aminoethylmethylsulfone hydrochloride | 104458-24-4 | 99% |
| Sorafenib tosylate | 475207-59-1 | 99% |
| Sorafenib tosylate | 284461-73-0 | 99% |
| 4-(4-Aminophenoxy)-N-methylpicolinamide | 284462-37-9 | 99% |
| 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid | 641569-94-0 | 99% |
| Vandetanib | 443913-73-3 | 99% |
| Afatinib | 850140-72-6 | 99% |
| Pazopanib | 444731-52-6 | 99% |
| Dovitinib | 915769-50-5 | 99% |
| Regorafenib Hydrochloride | 835621-07-3 | 99% |
| Cinacalcet hydrochloride | 364782-34-3 | 99% |
| N-((R)-1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoroMethyl)phenyl)propanaMide | 1005450-55-4 | 99% |
| Ceritinib (LDK378) | 1032900-25-6 | 99% |
| 4-Amino-3-fluorophenol | 399-95-1 | 99% |
| 6-Hydroxy-7-methoxy-3,4-dihydroquinazolin-4-one | 179688-52-9 | 99% |
| LDK-378 dihydrochloride | 1380575-43-8 | 99% |
| 2,4,5-Trichloropyrimidine | 5750-76-5 | 99% |
| 1-AMINO-2-(ISOPROPYLSULPHONYL)BENZENE | 76697-50-2 | 99% |
| 5-Methyl-2-(1-Methylethoxy)-4- (4-piperidinyl)- BenzenaMine hydrochloride (1:2) | 1380575-45-0 | 99% |
| Osimertinib Mesylate(AZD9291) | 1421373-66-1 | 99% |
| 4-Pyrimidinamine, 2,5-dichloro-N-[2-[(1-methylethyl)sulfonyl]phenyl]- | 761440-16-8 | 99% |
| 4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitro- | 162012-67-1 | 99% |
| (S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine | 314771-76-1 | 99% |
| 4-QuinazolinaMine, N-(3-chloro-4-fluorophenyl)-6-nitro-7-[[(3S)-tetrahydro-3-furanyl]oxy]- | 314771-88-5 | 99% |
| Propanedinitrile, 2-[hydroxy(4-phenoxyphenyl)Methylene]- | 330792-68-2 | 99% |
| Propanedinitrile, 2-[Methoxy(4-phenoxyphenyl)Methylene]- | 330792-69-3 | 99% |
| 5-aMino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile | 330792-70-6 | 99% |
| 5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMine | 330786-24-8 | 99% |
| Intedanib | 656247-17-5 | 99% |
| Ibrutinib | 936563-96-1 | 99% |
| Axitinib | 319460-85-0 | 99% |
| Canertinib | 267243-28-7 | 99% |
| Canertinib dihydrochloride | 289499-45-2 | 99% |
| Regorafenib | 755037-03-7 | 99% |
| Mubritinib | 366017-09-6 | 99% |
| Crizotinib | 877399-52-5 | 99% |
| Alectinib | 1256580-46-7 | 99% |
| DacoMitinib | 1110813-31-4 | 99% |
